首页> 美国卫生研究院文献>PLoS Clinical Trials >The proteome of perilymph in patients with vestibular schwannoma. A possibility to identify biomarkers for tumor associated hearing loss?
【2h】

The proteome of perilymph in patients with vestibular schwannoma. A possibility to identify biomarkers for tumor associated hearing loss?

机译:前庭神经鞘瘤患者外周淋巴的蛋白质组学。是否可能确定与肿瘤相关的听力损失的生物标志物?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDue to the surrounding bone, the human inner ear is relatively inaccessible and difficult to reach for cellular and molecular analyses. However, these types of investigations are needed to better understand the etiology, pathophysiology and progression of several inner ear disorders. Moreover, the fluid from the inner ear cannot be sampled for micro-chemical analyses from healthy individuals in vivo. Therefore, in the present paper, we studied patients with vestibular schwannoma (VS) undergoing trans-labyrinthine surgery (TLS). Our primary aim was to identify perilymph proteins in patients with VS on an individual level. Our second aim was to investigate the proteins identified at a functional level and our final aim was to search for biological markers for tumor-associated hearing loss and tumor diameter.
机译:背景技术由于周围的骨头,人内耳相对难以接近,难以进行细胞和分子分析。但是,需要进行这些类型的研究才能更好地了解几种内耳疾病的病因,病理生理和进展。而且,不能从体内抽取来自内耳的液体用于进行微量化学分析。因此,在本文中,我们研究了接受前路迷路手术(TLS)的前庭神经鞘瘤(VS)患者。我们的主要目的是在个体水平上鉴定VS患者的外周淋巴蛋白。我们的第二个目标是研究在功能水平上鉴定出的蛋白质,我们的最终目标是寻找与肿瘤相关的听力损失和肿瘤直径的生物学标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号